Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Immunology stories

Oct 5, 2026

Vaxcyte pneumococcal vaccine succeeds in Phase 3 trial

Vaxcyte's experimental pneumococcal vaccine generated immune responses comparable to Pfizer and Merck vaccines in a Phase 3 trial, positioning it to compete in the lucrative vaccine market.

Oct 5, 2026·3 sources
00
Sep 1, 2026

GSK advances mRNA flu vaccine to late-stage trial after strong mid-stage results

GSK will advance its mRNA-based seasonal influenza vaccine to late-stage trials after mid-stage data showed it generated stronger immune responses than currently approved flu vaccines.

Sep 1, 2026·2 sources
00
May 5, 2026

UCB Acquires Maker of Antibody Treatments for Autoimmune Diseases

Belgian pharmaceutical company UCB has announced the acquisition of a company specializing in antibody treatments for autoimmune diseases, expanding its immunology portfolio.

May 5, 2026·1 source
00
Apr 12, 2026

Researchers Discover Chloride Channel PACC1 as New Target for Sepsis Treatment

Scientists have identified a previously unknown immune mechanism where the chloride channel PACC1 plays a crucial role in helping immune cells kill bacteria, offering a potential new therapeutic target for sepsis.

Apr 12, 2026·1 source
00
Apr 11, 2026

COVID-19 Spike Protein Linked to Increased Lung Cancer Risk Through Inflammatory Pathway

New study suggests SARS-CoV-2 may slightly increase lung cancer risk by triggering a biological chain reaction driven by the virus's spike protein that promotes inflammation and tumor development.

Apr 11, 2026·1 source
00
Apr 7, 2026

High-Fat Diets Linked to Rapid Loss of Protective Gut Immune Cells

Mass General Brigham researchers found that even short-term exposure to high levels of dietary fat results in quick and selective loss of critical gut immune cells in preclinical study.

Apr 7, 2026·1 source
00
Apr 6, 2026

Mayo Clinic Develops Method to Identify Immune-Triggering Proteins in Transplants

Mayo Clinic researchers have developed a new method to identify which proteins are most likely to trigger an immune response, a discovery that could help improve transplant care and regenerative medicine outcomes.

Apr 6, 2026·1 source
00

Scripps Research Develops New Anti-Inflammatory Drug Class That Preserves Immune Function

Scripps Research scientists have developed a first-in-class drug compound that reduces harmful inflammation while leaving the body's ability to fight infections intact, addressing a long-sought goal in treating autoimmune diseases.

Apr 6, 2026·1 source
00
Apr 5, 2026

Research Team Discovers Dermcidin Exhibits Antiviral Activity Against Influenza

A research team led by the Fisabio Foundation has demonstrated that dermcidin, an antimicrobial peptide naturally produced by the human body, also shows antiviral activity against the influenza virus.

Apr 5, 2026·1 source
00

Top claims

  • ▪Pfizer's pneumococcal vaccine business was built on a 13-strain shot that emerged in 2010 and later expanded to a 20-strain alternative
  • ▪Jefferies analyst Roger Song stated that the trial results hit the blue-sky case, positioning VAX-31 to capture significant share of the adult vaccine market
  • ▪Vaxcyte expects to report results from two additional late-stage clinical trials of VAX-31 in the first half of 2027

Topics

Vaccine development and innovationVaccine developmentClinical trialsVaccines and Immunization PolicyDrug Policy, Pricing & ApprovalDrug Approval and Clinical TrialsPharmaAutoimmune disease treatmentsPharmaceutical IndustryInfectious Disease and OutbreaksInflammation reduction & immune effectsBiomarkers & bloodwork testingHealthNutrition fundamentalsFatsNutrition & Dietary PatternsLongevity & biohackingDrug Classes & Treatment Access

Related entities

MerckPfizerInfluenza VaccineBelgiumSepsisSARS-CoV-2COVID-19Lung cancerNutritionMass General BrighamLupusAutoimmune disease